Previous 10 | Next 10 |
PlantArcBio announces collaboration agreement with Bioceres Crop Solutions to develop improved biomass & drought tolerant Alfalfa PlantArcBio announces collaboration agreement with Bioceres Crop Solutions to develop improved biomass & drought tolerant Alfalfa PR News...
LuminUltra named 2021 Company of the Year by Water Canada Canada NewsWire FREDERICTON, NB , June 16, 2021 /CNW/ - LuminUltra has been named '2021 Company of the Year' by Water Canada's Water's Next awards program, which recognizes individuals,...
Aequor Technologies Announces Acquisition of HireLifeScience.com HireLifeScience Fuels Aequor's Expansion in The Life Sciences Industry PR Newswire PISCATAWAY, N.J. , June 16, 2021 /PRNewswire/ -- Aequor Technologies, LLC, a Life Sciences Strategic Staffing a...
Debiopharm and Ubix Therapeutics Launch Research to Develop a New Anti-Cancer Modality - Antibody Degraducer® Conjugates PR Newswire LAUSANNE , Switzerland and SEOUL, South Korea , June 16, 2021 /PRNewswire/ -- Debiopharm ( www.debiopharm...
DarioHealth Expands Footprint in Musculoskeletal Sensor Technologies with the Upright GO S New biofeedback sensor improves access to back health solutions and is aimed at increasing membership on Dario's integrated personalization platform PR Newswire NEW YORK , ...
Amyris to Present at the Jefferies Virtual Consumer Conference on June 23, 2021 PR Newswire EMERYVILLE, Calif. , June 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty market...
GT Biopharma to Present at Raymond James Human Health Innovation Conference PR Newswire BEVERLY HILLS, Calif., June 16, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused...
ImmunoGenesis Announces Publication of Phase 1 Data on its Hypoxia-Reversal Agent Highlighting Efficacy and Genetic Expression Correlatives in Advanced Cancer Data reported in Clinical Cancer Research support the efficacy of evofosfamide in combination with checkpoint inhibition...
Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members PR Newswire FREDERICK, Md. , June 16, 2021 /PRNewswire/ -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule thera...
New study confirms that social determinants of health challenges are prevalent among commercially-insured populations Analysis of a large commercially-insured population shows that more than a quarter of the workforce is vulnerable to SDoH barriers to care PR Newswire ...
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
2024-05-09 12:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compare...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...